SU2C Launches $7.5 Million Initiative in Research Grants Focusing on Immuno-oncology



Stand Up To Cancer (SU2C) is making $7.5 million in research grants available to early-career scientists who are pursuing innovative cancer research projects focusing on immuno-oncology, the American Association for Cancer Research recently announced. Funded by a grant from SU2C Visionary Supporter, Bristol-Myers Squibb Company, a total of 10 Innovative Research Grants will be available, each up to $750,000, over 3 years. 

William G. ­Kaelin, Jr, MD

William G. ­Kaelin, Jr, MD

“Immuno-oncology is an exciting field in research today,” said ­William G. ­Kaelin, Jr, MD, Professor of Medicine and Associate Director of Basic Science at the Dana-Farber Cancer Institute and Harvard Medical School, and Chair of the SU2C Innovative Research Grant Committee. “It has yielded a number of revolutionary new approaches to cancer treatment, and we are eager to find and support scientists early in their careers who can help move the field even further forward.”

The Innovative Research Grant program is open to young investigators no more than 7 years into their first independent, tenure-track (or equivalent) appointment, pursuing novel, high-risk, high-reward cancer immunology research proposals that have significant potential for translation to clinical application and hold great promise for advancing SU2C’s overarching goal of improving and saving lives. Provided that these criteria are met, proposals may focus on any discipline within basic, translational, or clinical research.

Critical Investment

“There is potential for immuno-oncology in a wide range of cancers, and so investment in new research is critical,” said Julie Hambleton, MD, Vice President, Head, U.S. Medical, Bristol-Myers Squibb. “As part of our ongoing support of SU2C, we are proud to help the next generation of researchers progress the field forward with new and exciting research that has the potential to lead to advancements for the benefit of patients.”

The deadline for proposals from eligible investigators is 12:00 PM ET on January 12, 2017. See the program guidelines at http://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=62, and submit proposals online via proposalCENTRAL at https://proposalcentral.altum.com. ■



Advertisement

Advertisement



Advertisement

click me